Progesterone Receptor-negative Breast Cancer Recruiting Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028547 (Progesterone Receptor-negative Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01750073Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Breast CancerTreatment